In a new French-Hungarian study, the co-formulants of glyphosate herbicides are shown to be endocrine disruptors, i.e. to interfere with the human hormone system. Two ENSSER board members, Nicolas Defarge and András Székács, are involved in the study.

Despite a great deal of scientific criticism pointing at serious potential health hazards, the European Commission has recently proposed to extend the approval of the world's most popular herbicide glyphosate for another 15 years. One of the points of criticism is that both the EU risk assessment and the acceptable daily intake (ADI) refer only to the active substance glyphosate, while the commercial product ('formulation') contains more substances: 'co-formulants' are added to modify the physico-chemical properties or to improve penetration or stability of the active substance. The co-formulants are usually presented as inert and their identity is generally protected as 'confidential business information'. However, the new study demonstrates that known co-formulants of six commercial glyphosate formulations have endocrine-disrupting effects by themselves.

The endocrine disrupting effects of the co-formulants were assessed by measuring the activity of aromatase, a key enzyme for the balance of sex hormones, in human placental cells, using a method validated by the OECD to assess endocrine disruptors. Aromatase is responsible for the irreversible conversion of male sex hormones into female sex hormones.